Experimental Immunotherapy Could Help High-Risk Bladder Cancer Patients Skip Cystectomy
A Mayo Clinic–led international phase 3 trial reports that a new intravesical oncolytic immunotherapy, cretostimogene grenadenorepvec, may help many people ...
A Mayo Clinic–led international phase 3 trial reports that a new intravesical oncolytic immunotherapy, cretostimogene grenadenorepvec, may help many people ...
In a groundbreaking advancement in the fight against glioblastoma, a collaborative team of researchers from Mass General Brigham and the ...
In a groundbreaking advancement at the intersection of virology and oncology, researchers have unveiled a revolutionary approach that harnesses a ...
The landscape of cancer treatment is undergoing a profound transformation, driven in large part by the innovative integration of oncolytic ...
In a groundbreaking advance that could reshape the therapeutic landscape of one of the deadliest pediatric brain cancers, scientists have ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine